Refined Laser Systems, a Münster, Germany-based dynamic biophotonics company specialised in pioneering laser systems for SRS-microscopy and quantum technology, raised €2.7M in funding.
The round was led by High-Tech Gründerfonds and APEX Ventures, with participation from NRW.BANK, Onsight Ventures, Papst Venture Capital, Tom Merk, Hans-Michael Hauser, and Dr Werner Falkenstein.
The company intends to use the funds to develop an intraoperative microscope prototype that identifies tumor margins directly in the surgery room and will offer a diagnosis within minutes by a remote pathologist and AI assistance. The team also plans to use the capital to grow its team and prepare for clinical approval.
Founded in 2019 as a spin-off from University of Münster by Max Brinkmann, Tim Hellwig and Christoph Seidenstücker, Refined Laser Systems has developed an innovative microscopy procedure to support pathology in diagnosing cancer within minutes and avoid revision surgeries. The core of the prototype produced by the compact will be laser technology, already used worldwide, and an imaging system that will be operational in 2023.
Its core expertise is the development of laser and microscopy technology. Its PICUS DUO and PICUS Q laser systems are used worldwide as key components for SRS microscopy and quantum technology.
FinSMEs
30/01/2023